Cotización Telesis Bio - TBIO

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

3.23

Postura de Compra

3.15

Postura de Venta

3.35

Volume Operado de la Acción

0.00 Rango del Día 0.00

1.27 Rango de 52 semanas 19.62

Capitalización de Mercado [m]

5.727M

Precio Anterior

3.23

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

1,460,305

Acciones en circulación

1,772,946

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.12

Beneficio por acción (BPA)

-27.65

turnover

27.51M

Beneficio neto

-49.02M

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Mostrar más

Sector

Lab Analytical Instruments

Industria

Lab Analytical Instruments

Sitio web

www.codexdna.com

Sede

Wilmington, Delaware, USA

Fundado

Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was US$3.23. Over the last year, Telesis Bio shares have traded in a share price range of US$ 1.27 to US$ 19.62.

Telesis Bio currently has 1,772,946 shares in issue. The market capitalisation of Telesis Bio is US$5.73 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.12.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	3.23	3.6168	2.8556	375990	3.23	CS
4	-0.82	-20.2469135802	4.05	5.08	1.27	4005682	3.22963664	CS
12	-0.28	-7.97720797721	3.51	6.06	1.27	1460305	3.32288404	CS
26	-5.212	-61.7389244255	8.442	8.4582	1.27	726752	3.45171246	CS
52	-14.41	-81.6893424036	17.64	19.62	1.27	614314	6.13957369	CS
156	-669.25	-99.5196883179	672.48	672.48	1.27	231870	9.56490266	CS
260	-172.99	-98.1670638974	176.22	683.73	1.27	599784	324.62352762	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
PETZTDH Holdings Inc	US$ 1.70 (25.09%)	3.36M
CNETZW Data Action Technologies Inc	US$ 2.75 (11.79%)	2.07k
CHNRChina Natural Resources Inc	US$ 0.80 (11.11%)	4.07k
METCBRamaco Resources Inc	US$ 11.60 (10.58%)	100
XRTXXORTX Therapeutics Inc	US$ 1.6999 (10.38%)	2.67k
TRVNTrevena Inc	US$ 2.59 (-43.76%)	106.83k
CTNTCheetah Net Supply Chain Service Inc	US$ 0.2285 (-19.47%)	2.27M
CETXCemtrex Inc	US$ 1.62 (-19.40%)	1.36M
CHSNChanson International Holding	US$ 12.28 (-17.08%)	5.2M
FRZAForza X1 Inc	US$ 0.28 (-15.15%)	67.82k
ELABElevai Labs Inc	US$ 0.1177 (8.98%)	7.41M
CHSNChanson International Holding	US$ 12.28 (-17.08%)	5.2M
NXUNXU Inc	US$ 0.2595 (1.53%)	4.25M
PETZTDH Holdings Inc	US$ 1.70 (25.09%)	3.36M
SQQQProShares UltraPro Short QQQ	US$ 7.44 (0.13%)	3.01M